Regular Exercise in Middle Age Lowers Inflammatory Markers

This article originally appeared here.
Share this content:
Regular Exercise in Middle Age Lowers Inflammatory Markers
Regular Exercise in Middle Age Lowers Inflammatory Markers

(HealthDay News) -- Middle-aged adults who have regularly engaged in physical activity for more than a decade appear to benefit from lower markers of inflammation, according to a study published online Aug. 13 in Circulation.

Mark Hamer, Ph.D., from University College London, and colleagues examined the association between physical activity and inflammatory markers over a 10-year follow-up period using data from 4,289 men and women (mean age, 49.2 years) from the Whitehall II cohort study. At baseline (1991) and follow-up (2002), self-reported physical activity and inflammatory markers (serum high-sensitivity C-reactive protein and interleukin-6) were measured.

The researchers found that, across all assessments, 49 percent of the participants adhered to standard physical activity recommendations for cardiovascular health (2.5 hours/week of moderate-to-vigorous physical activity). At baseline, physically active participants had lower C-reactive protein and interleukin-6 levels, with this difference persisting over time. Over the 10-year follow-up period, the high-adherence group had lower loge C-reactive protein and loge interleukin-6, after adjustment for covariates, compared to participants who rarely adhered to physical activity guidelines. Participants who reported an increase in physical activity of at least 2.5 hours/week displayed lower loge C-reactive protein and loge interleukin-6 at follow-up, compared to participants whose exercise remained stable.

"The results show that physically active participants maintain lower levels of inflammatory markers over a 10-year period," the authors write. "Thus, physical activity may be important in preventing the proinflammatory state seen with aging."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs